Despite the detection of elevated levels of O‐GlcNAcylation in various cancer types, our study presents novel evidence demonstrating the physiological O‐GlcNAcylation of NRF2, which is implicated in tumour malignancy and cisplatin resistance. Here, NFE2L2 is linked to cancer.